Released Aug 15, 2016, during market hours
10-Q filed Aug 15, 2016, 46 days after period end · 0001213900-16-015974
Q2 2016 · 10-Q
Revenue—
Net Income-$4.39M-$4.39M N/M vs Q2 2015N/M vs Q1 2016
EPS Diluted-$6.30-$6.30 — vs Q2 2015N/M vs Q1 2016
Operating Income-$4,377,433N/M
Operating Cash Flowderived-$2,950N/M
Free Cash Flowderived-$5,798—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | -$4.39M | -$7.27K | -$6.95K | -$6.75K |
| EPS Diluted | -$6.30 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR